After piloting new Clostridioides difficile guidelines for nine months, Memorial Healthcare System reduced unnecessary treatments by 20.1%, according to a study published June 27 in the American Journal of Infection Control.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
